Alpha Profiles · Company Profile

ImmunityBio, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/immunitybio-inc

Entity: Public listing published
Primary listing: NASDAQ: IBRX
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:31.901686+00:00

Overview

Alpha's canonical identity and public leadership record for ImmunityBio, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

David Sachs

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IBRX executive roster sourceMay 3, 2026

Patrick Soon-Shiong

Chairman and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IBRX executive roster sourceMay 3, 2026

Richard Adcock

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: IBRX executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.